Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2002
10/03/2002WO2002076384A2 Therapeutic compositions that alter the immune response
10/03/2002WO2002076377A2 Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002068687A8 Function and application of tob gene in central nervous system of mammal
10/03/2002WO2002059153A3 Anticoagulants and their uses
10/03/2002WO2002058728A3 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/03/2002WO2002055109A3 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
10/03/2002WO2002044206A3 Membrane fusion proteins derived from reovirus
10/03/2002WO2002034933A3 Methods and compositions for modifying biologically active target molecules
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002WO2002009744A3 Modified sialic acid vaccines
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001020989A9 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
10/03/2002WO2001019846A9 Transgenically produced fusion proteins
10/03/2002US20020144298 Novel human genes and gene expression products
10/03/2002US20020143159 Bone morphogenetic protein (bmp)-17 and bmp-18 compositions
10/03/2002US20020143157 Immunoglobulin for use in the treatment and prevention of microorganismal infections
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002US20020142986 Used in the diagnosis or prognosis of liver associated disorders
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142982 Method for regulating angiogenesis
10/03/2002US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors
10/03/2002US20020142456 Protein for use in the treatment of body weight defects
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142445 Peptides for use in the treatment of tumors and graft versus host disease
10/03/2002US20020142444 AL-2 neurotrophic factor
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142432 Human endosulfine gene
10/03/2002US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
10/03/2002US20020142429 Elongation factor-2 kinase (EF-2 kinase) and methods of use therefor
10/03/2002US20020142428 Novel kinases and uses thereof
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142418 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002US20020142374 Generating genetically engineered antibody with expanded half-life; obtain nucleotide sequences, insert segment coding preferential immunoglobulin fragment, recover protein
10/03/2002US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002US20020142358 Antibody for use in the diagnosis, prevention and treatment of infections, multiple sclerosis, arthritis, autoimmune, inflammation and graft versus host disease
10/03/2002US20020142357 TNF receptor action modulation
10/03/2002US20020142356 Immunoassay for C-reactive protein
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142322 Method for evaluating the intensity of muscular proteolysis
10/03/2002US20020142316 Mutants of the factor VII-activating protease and detection methods using specific antibodies
10/03/2002US20020142001 DNA immunization against Chlaymdia infection
10/03/2002US20020142000 Genetic engineering
10/03/2002US20020141997 Hybridoma cells; genetic engineering
10/03/2002US20020141996 Methods of treating infections with chimeric anti-TNF antibodies
10/03/2002US20020141995 Using transforming growth factor
10/03/2002US20020141994 Antiischemic agents, antiinflammatory agents, autoimmune disease
10/03/2002US20020141993 Apoptosis; anticancer agents
10/03/2002US20020141992 Deactivation of collagen receptors
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141990 Genetic engineering; neutralizing infections
10/03/2002US20020141989 Antiinflammatory agents; antiallergens
10/03/2002US20020141988 Therapeutic agent for acute lung injury resulting from indirect causes comprising anti-il-8 antibody as active ingredient
10/03/2002US20020141941 PSCA: prostate stem cell antigen and uses thereof
10/03/2002CA2443676A1 A novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof
10/03/2002CA2442318A1 Antibodies against cancer
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002CA2442077A1 Novel nucleic acids and polypeptides
10/03/2002CA2442010A1 New elongase gene and production of.delta. 9-polyunsaturated fatty acids
10/03/2002CA2441953A1 Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors
10/03/2002CA2441721A1 Human potassium channel
10/03/2002CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441588A1 Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441551A1 Pathogenic and commensal vaccine antigens
10/03/2002CA2441393A1 Therapeutic compositions that alter the immune response
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441228A1 Combination treatment of pancreatic cancer
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002CA2438206A1 Transporters and ion channels
10/03/2002CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002CA2425862A1 Cd19-specific redirected immune cells
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245671A1 Nucleic acids encoding human telomerase subunits displaying homology to yeast est1
10/02/2002EP1245575A2 Functionally active selectin-derived peptides and ligand for GMP140
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244791A2 Method for producing 6-0-alpha-d-glucopyranosyl-d-sorbite
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
1 ... 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 ... 1494